Abstract:Beginning in the 1960s, animal and cell culture studies have demonstrated that transcranial photobiomodulation (t-PBM), which involves photons in the red and near-infrared spectrum, can penetrate the cerebral cortex and enhance the mitochondrial electron transport chain [1] (fNIRS similarly uses near infrared photons to image the brain, but at lower light intensities and exposure, resulting in minimal impact on brain function). Emerging human t-PBM data have demonstrated behavioral and clinical effects in multiple patient populations, along with effects on cerebral metabolism and hemodynamics, highlighting its potential therapeutic efficacy [1]. For example, small studies suggested that t-PBM delivered with both high (700 mW/cm 2 ) and low (36 mW/cm 2 ) irradiance [2] is effective in the treatment of major depressive disorder (MDD). However, since other studies with low t-PBM irradiance (55 mW/cm 2 ) did not replicate the positive results in MDD [3], it becomes critically important to further understand the irradiance dose-dependent neurobiological mechanisms of t-PBM, as we are attempting in our ongoing clinical trial [4]. t-PBM has an excellent safety profile [1,2,3], and it can be performed in multiple settings, including during magnetic resonance imaging (MRI) or other neuroimaging modalities, to quantify the impact on brain bioenergetics noninvasively and in real-time. However, work is still underway to determine the optimal parameters for clinical utility. Our team has recently demonstrated the effect of t-PBM, at medium irradiance (300 mW/cm 2 ), on regional intrinsic brain activity in 19 individuals with early Alzheimer's disease [AD] [5]. In this publication [5], we found that t-PBM altered the fractional amplitude of low-frequency fluctuations (fALFF) across all laser-irradiated brain cortical regions, which are limited to frontal regions due to skull density and hair interference. fALFF, assessed non-invasively during resting-state MRI, is a voxel-based measure of intrinsic brain activity measuring the regional brain metabolism: it is strongly correlated with cerebral glucose metabolism measured by [ 18 F]Fluorodeoxyglucose positron emission tomography. Similarly, other studies have reported increases in MRI BOLD signal (also in t-PBM-irradiated brain areas, at 300 mW/cm 2 irradiance) in healthy volunteers [6]. The increase in fALFF we detected in t-PBM-irradiated brain areas during stimulation [5], and the similar increases in MRI BOLD signal [6], suggest that t-PBM can increase intrinsic brain activity (and specifically cerebral metabolism) in real time; these effects continue briefly after t-PBM administration has ended.

Photobiomodulation for Global Cerebral Ischemia: Targeting Mitochondrial Dynamics and Functions

Photobiomodulation Therapy Attenuates Hypoxic-Ischemic Injury in a Neonatal Rat Model

Photobiomodulation improves functional recovery after mild traumatic brain injury

Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia‐ischemia

Photobiomodulation promotes repair following spinal cord injury by restoring neuronal mitochondrial bioenergetics via AMPK/PGC-1α/TFAM pathway

Abstract WP14: Photobiomodulation Treatment Enhancesand Sustains Neurogenesis Following Acute Ischemic Stroke

Brain photobiomodulation therapy on neurological and psychological diseases

Photobiomodulation and the brain: a new paradigm

Mechanism of PGC-1α-mediated mitochondrial biogenesis in cerebral ischemia–reperfusion injury

Photobiomodulation augments the effects of mitochondrial transplantation in the treatment of spinal cord injury in rats by facilitating mitochondrial transfer to neurons via Connexin 36

Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics

Red light photobiomodulation rescues murine brain mitochondrial respiration after acute hypobaric hypoxia

Recent Advances in Photobiomodulation Therapy for Brain Diseases

Photobiomodulation therapy alleviates repeated closed head injury‐induced anxiety‐like behaviors

Traumatic Brain Injury Recovery with Photobiomodulation: Cellular Mechanisms, Clinical Evidence, and Future Potential

Implantable and transcutaneous photobiomodulation promote neuroregeneration and recovery of lost function after spinal cord injury

Photobiomodulation inhibits the activation of neurotoxic microglia and astrocytes by inhibiting Lcn2/JAK2-STAT3 crosstalk after spinal cord injury in male rats

Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics

Photobiomodulation therapy for repeated closed head injury in rats

Photobiomodulation Inhibits Ischemia-Induced Brain Endothelial Senescence via Endothelial Nitric Oxide Synthase

Activation of the AKT/GSK-3β/β-catenin pathway via photobiomodulation therapy promotes neural stem cell proliferation in neonatal rat models of hypoxic-ischemic brain damage